Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ-3989
JNJ-3989
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy
Reuters
Tue, 10/31/23 - 10:18 am
GSK
JNJ
hepatitis B
JNJ-3989
Janssen
J&J's RNAi suppresses hepatitis B for 48 weeks after last dose
Fierce Biotech
Fri, 08/28/20 - 10:47 am
JNJ
RNAi
JNJ-3989
hepatitis B